Multiprofile Hospital For Active Treatment Sveti Nikolay Chuditvorets EOOD

The Department of Hemodialysis is conducting a study aimed at improving safety for patients on FXa inhibitors who require urgent surgery, evaluating a reversal agent to quickly stop bleeding.

• Management of peri‑operative bleeding
• Evaluation of reversal agents
• Risk reduction in cardiovascular patients

This work, carried out at Multiprofile Hospital For Active Treatment Sveti Nikolay Chuditvorets EOOD, supports better outcomes for individuals with acute cardiovascular complications.

A clinical trial is assessing the effectiveness of a novel therapy, PLS240, in lowering parathyroid hormone levels for patients with secondary hyperparathyroidism undergoing chronic hemodialysis.

• Reduction of iPTH levels
• Long‑term safety monitoring
• Improvement of mineral‑bone health

Findings from this investigation at the Lom facility may enhance treatment strategies for endocrine complications in end‑stage kidney disease.

Although the current portfolio emphasizes renal and cardiovascular studies, the department maintains expertise in addressing female urogenital diseases and pregnancy‑related complications within the hemodialysis population.

• Monitoring of reproductive health in dialysis patients
• Assessment of pregnancy outcomes
• Integration of gender‑specific care

The hospital’s multidisciplinary approach ensures comprehensive support for women receiving active treatment.

The site also explores issues related to male urogenital diseases in patients undergoing dialysis, focusing on hormonal balance and quality of life.

• Evaluation of testosterone levels
• Management of sexual dysfunction
• Coordination with nephrology care

By integrating these considerations, the research aims to improve overall wellbeing for male patients at the hospital.